BREATHE: An Efficacy-implementation With Listening Sessions

NCT05045690 | Completed

• 2 other identifiers: AAAT0939 - pre-trial1R01NR019275
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Listening sessions: The research team will collect qualitative data from the listening sessions (focus groups) using a semi-structured iterative focus group guide.

Conditions

Asthma

Outcome Measures

Primary Outcomes (2)

• Number of participants who completed listening sessions

  Listening sessions (research focus groups) will be held pre-trial to explore experiences with asthma and clinical research. Sharing from these sessions will be observational in nature where information will be collected to aid the design/implementation of other portions in this project.

  Visit 1 (approximately 120 minutes)

• Number of participants who completed clinician/administrator pre-trial interviews

  Interviews will be held pre-trial to explore experiences with asthma and clinical research. Sharing from these sessions will be observational in nature where information will be collected to aid the design/implementation of other portions in this project.

  Visit 1 (approximately 30 minutes)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants will be recruited from federally qualified health centers (FQHCs)

You may qualify if:

• be adults (\> 18 years of age or emancipated)
• self-report 'black' race (African American, African, Caribbean, West Indian, multi-racial \[black AND one or more additional races\]); identify their ethnicity as Hispanic OR non-Hispanic
• have clinician-diagnosed asthma
• receive asthma care at a partner federally-qualified health center (FQHC)

You may not qualify if:

• non-English speaking
• serious mental health conditions that preclude completion of study procedures or confound analyses
• participation in a listening session

Sponsors & Collaborators

• Columbia University: lead
• Clinical Directors Network: collaborator
• National Institute of Nursing Research (NINR): collaborator

Study Sites (1)

Clinical Directors Network

New York, New York, 10018, United States

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Maureen T George, PhD

  Columbia University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Nursing at the Columbia University Medical Center

Study Record Dates

• First Submitted: September 7, 2021
• First Posted: September 16, 2021
• Study Start: November 19, 2021
• Primary Completion: June 9, 2022
• Study Completion: June 9, 2022
• Last Updated: January 10, 2023

Record last verified: 2023-01

Locations

US (1)